105 related articles for article (PubMed ID: 3970812)
1. Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol.
Clarke R; Van den Berg HW; Kennedy DG; Murphy RF
Br J Cancer; 1985 Mar; 51(3):365-9. PubMed ID: 3970812
[TBL] [Abstract][Full Text] [Related]
2. Reduction of the anti-metabolic and anti-proliferative effects of methotrexate by 17 beta-oestradiol in a human breast carcinoma cell line, MDA-MB-436.
Clarke R; Van den Berg HW; Kennedy DG; Murphy RF
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):19-24. PubMed ID: 6682774
[TBL] [Abstract][Full Text] [Related]
3. In vitro estradiol-sensitivity characterization of the MCF-7, ZR-75, MDA-MB-231 and T47-D human breast neoplastic cell lines.
Camby I; Kiss R
Anticancer Res; 1993; 13(6A):2355-60. PubMed ID: 8297158
[TBL] [Abstract][Full Text] [Related]
4. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
Das JR; Fryar-Tita EB; Zhou Y; Green S; Southerland WM; Bowen D
Anticancer Res; 2007; 27(6B):3791-9. PubMed ID: 18225534
[TBL] [Abstract][Full Text] [Related]
5. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
6. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
[TBL] [Abstract][Full Text] [Related]
7. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
8. Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.
Levenson AS; Kwaan HC; Svoboda KM; Weiss IM; Sakurai S; Jordan VC
Br J Cancer; 1998 Jul; 78(1):88-95. PubMed ID: 9662256
[TBL] [Abstract][Full Text] [Related]
9. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
10. Oestradiol stimulates growth of oestrogen receptor-negative MDA-MB-231 breast cancer cells in immunodeficient mice by reducing cell loss.
Friedl A; Jordan VC
Eur J Cancer; 1994; 30A(10):1559-64. PubMed ID: 7833119
[TBL] [Abstract][Full Text] [Related]
11. Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells.
Nutt JE; Harris AL; Lunec J
Br J Cancer; 1991 Oct; 64(4):671-6. PubMed ID: 1911215
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression.
Reddy KB; Yee D; Hilsenbeck SG; Coffey RJ; Osborne CK
Cell Growth Differ; 1994 Dec; 5(12):1275-82. PubMed ID: 7696176
[TBL] [Abstract][Full Text] [Related]
13. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
Reddel RR; Sutherland RL
Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative-antiinflammatory effects of methotrexate and sex hormones on cultured differentiating myeloid monocytic cells (THP-1).
Cutolo M; Sulli A; Craviotto C; Felli L; Pizzorni C; Seriolo B; Villaggio B
Ann N Y Acad Sci; 2002 Jun; 966():232-7. PubMed ID: 12114277
[TBL] [Abstract][Full Text] [Related]
15. Failure of 5-fluorouracil and methotrexate to destroy the reproductive integrity of a human breast cancer cell line (MCF-7) growing in vitro.
Van den Berg HW; Clarke R; Murphy RF
Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1275-81. PubMed ID: 7200028
[No Abstract] [Full Text] [Related]
16. Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17 beta-estradiol.
Clarke R; van den Berg HW; Murphy RF
J Natl Cancer Inst; 1990 Nov; 82(21):1702-5. PubMed ID: 2231758
[TBL] [Abstract][Full Text] [Related]
17. Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines.
Lykkesfeldt AE; Briand P
Br J Cancer; 1986 Jan; 53(1):29-35. PubMed ID: 3947513
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
19. Proliferative inhibition of human breast carcinoma cells by high concentration estradiol does not alter radiosensitivity.
Wazer DE; Joyce M; Solares G; Schmidt-Ullrich R
Breast Cancer Res Treat; 1991 Aug; 18(3):141-8. PubMed ID: 1756256
[TBL] [Abstract][Full Text] [Related]
20. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
